Meloxikam Fmk (Meloxicam)

Meloxicam works by preferentially inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the formation of prostaglandins—chemical mediators that drive inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam reduces these symptoms while preserving some COX‑1 activity that protects the stomach lining.

The appropriate dose of Meloxikam Fmk is determined by the prescribing clinician based on the patient’s condition, severity, and overall health. Dosage adjustments may be needed for renal or hepatic impairment, and the prescriber will provide the specific regimen.

The safety of meloxicam in pregnancy and lactation has not been definitively established. It is generally avoided during the first trimester and throughout pregnancy unless the potential benefit outweighs the risk. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Meloxicam offers a longer half‑life and greater COX‑2 selectivity than many traditional NSAIDs such as ibuprofen or naproxen, which can translate into once‑daily dosing and potentially lower gastrointestinal risk. However, it still shares class‑related cautions, especially regarding cardiovascular and renal safety.

Meloxikam Fmk should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain potency throughout the shelf life.

Meloxikam Fmk is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce stomach upset. Patients should follow the prescriber’s instructions regarding timing and any dose adjustments.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, and renal impairment. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Meloxikam Fmk should be avoided in individuals with known hypersensitivity to meloxicam, other oxicams, or any component of the formulation. It is also contraindicated in patients with active gastrointestinal bleeding, severe heart failure, or those who have had a recent coronary artery bypass graft surgery.